Table 3.

Effects of BSHXR on implantation and pregnancy outcome in mice.

Groups	Control	Model	BSHXR1 (11.4 g/kg)	BSHXR2 (5.7 g/kg)
Pregnancy rate (%)	71.43 (30/42) × 100	55.56 (30/54) × 100	65.22 (30/46) × 100	55.36 (31/56) × 100
No. of implantation on D5 (N = 10)	13.50 ± 1.58	18.90 ± 2.73	14.90 ± 3.73	15.30 ± 2.00
No. of implantation on D6 (N = 10)	13.10 ± 1.79	17.50 ± 4.25	13.80 ± 2.62	14.30 ± 3.47
No. of implantation on D8 (N = 10)	12.00 ± 2.87	11.60 ± 3.47	13.50 ± 2.01	13.00 ± 3.74
No. of live fetuses (N = 6)	11.67 ± 1.21	7.50 ± 6.72	12.00 ± 2.10	11.17 ± 3.55
No. of dead fetuses (N = 6)	0	4 (0,8.5)∗	0	0
Gestation period (days) (N = 6)	20.00 ± 0.63	22.00 ± 0.89∗∗∗	20.00 ± 0.00###	20.00 ± 1.10###
Post-implantation Loss (%)	13.56 (13.50–11.67/13.50) × 100	60.32∗ (18.90–7.50/18.90) × 100	19.46# (14.90–12/14.90) × 100	26.99 (15.30–11.17/15.30) × 100

Data with a normal distribution represent as mean ± SD, and data with a skewed distribution represent as medians (first quartile, third quartile). ^∗P < 0.05 and ^∗∗∗P < 0.001 when compared to control group. ^#P < 0.05 and ^###P < 0.001 when compared to model group.